Abridge
Abridge, founded in 2018 in Pittsburgh, offers software that uses AI to listen to patient-physician conversations and automatically generate clinical notes and billing codes.
About
Abridge, founded in 2018 in Pittsburgh, offers software that uses AI to listen to patient-physician conversations and automatically generate clinical notes and billing codes. As of Q1 2025, Abridge's contracted annual recurring revenue reached $117 million.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Company· 12
Investor· 10
Founders / team· 1
Funding history
- 2025-06Series D+$300M
Investors · Andreessen Horowitz, Khosla VenturesSource · SVTR Weekly #111 ↗
- 2025-02Series D+$250M
Investors · Lightspeed, CVS Health Ventures, Redpoint Ventures, IVP, NVenturesSource · SVTR Weekly #093 ↗
- 2024-03Series C$150M
Investors · Lightspeed, Intel Capital, CVS Health Ventures, Redpoint Ventures, IVP, Mass General Brigham Artificial Intelligence and Digital Innovation Fund, Spark Capital, Kaiser Permanente Ventures, Wittington Ventures, Bessemer Venture Partners, Union Square VenturesSource · SVTR Weekly #042 ↗
- 2023-10Series B$30M
Investors · Spark Capital, Bessemer Venture PartnersSource · SVTR Weekly #025 ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Abridge
Provides software that lets AI listen to doctor-patient conversations and automatically generate medical records and billing codes
Series D+ · $800M · 2025-06
$800M
United States
BusinessLatest roundTotal raisedDate- Forus
AI automation of post-prescription healthcare administrative workflows (insurance verification, prior authorization, appeals…
Series C · $300M · 2026-09 · Valuation $3.0B
$300MValuation $3.0B - Cityblock Health
A value-based care platform providing primary care, behavioral health…
Series D+ · $1.0B · 2026-08
$1.0B - Precision Neuroscience
building the next generation of brain-computer interfaces (BCIs) with a minimally invasive, high-density implant
Series D+ · $430M · 2026-09
$430M
Europe
BusinessLatest roundTotal raisedDate- Tandem Health
AI clinical assistant for European healthcare providers: pre-visit summaries, real-time consultation transcription…
Series B · $160M · 2026-09
$160M - Voize
AI voice documentation assistant for frontline nursing that generates standardized nursing records automatically
Series A · $59M · 2025-11
$59M - Uncovr
Analyzes surgical and endoscopy video to generate operative notes and procedure billing codes automatically
Seed · $7M · 2026-06
$7M
Other / unspecified
BusinessLatest roundTotal raisedDate- Heidi Health
AI ambient documentation and clinical agent for clinicians (AI Care Partner)
Series C · $437M · 2026-09 · Valuation $900M
$437MValuation $900M - Craif
Urine microRNA plus AI early cancer detection service (miSignal) and software medical device development for pancreatic cancer diagnosis
Series D+ · $88M · 2026-08
$88M - Revena
Hospital billing automation
Seed · $8M · 2026-02
$8M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Y Combinator
39 Life Sciences deals in the last 24 months · 3 at a nearby stage · 32 in United States
Request intro →General Catalyst
38 Life Sciences deals in the last 24 months · 7 at a nearby stage · 34 in United States
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 8 at a nearby stage · 15 in United States
Request intro →8VC
15 Life Sciences deals in the last 24 months · 5 at a nearby stage · 15 in United States
Request intro →Lux Capital
15 Life Sciences deals in the last 24 months · 3 at a nearby stage · 15 in United States
Request intro →Insight Partners
14 Life Sciences deals in the last 24 months · 3 at a nearby stage · 13 in United States
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.